HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Communicable Diseases (Infectious Diseases)

An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
Also Known As:
Infectious Diseases; Infectious Disease; Diseases, Infectious; Communicable Disease; Diseases, Communicable; Disease, Communicable; Disease, Infectious
Networked: 25324 relevant articles (1245 outcomes, 2080 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Infections
3. Tuberculosis (Tuberculoses)
4. COVID-19
5. Malaria

Experts

1. Rappuoli, Rino: 34 articles (01/2022 - 05/2003)
2. Casadevall, Arturo: 26 articles (05/2022 - 09/2003)
3. Kiyono, Hiroshi: 26 articles (12/2021 - 09/2003)
4. AST Infectious Diseases Community of Practice: 22 articles (01/2019 - 01/2019)
5. Beekmann, Susan E: 21 articles (01/2022 - 12/2008)
6. Hersh, Adam L: 20 articles (06/2022 - 01/2011)
7. Polgreen, Philip M: 20 articles (01/2022 - 12/2008)
8. Esposito, Susanna: 20 articles (01/2021 - 10/2009)
9. Weiner, David B: 20 articles (06/2020 - 01/2003)
10. Zhang, Wei: 19 articles (05/2022 - 05/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Communicable Diseases:
1. VaccinesIBA
2. Anti-Bacterial Agents (Antibiotics)IBA
3. AntigensIBA
4. AntibodiesIBA
5. Proteins (Proteins, Gene)FDA Link
6. DNA (Deoxyribonucleic Acid)IBA
7. Anti-Infective Agents (Microbicides)IBA
8. DNA VaccinesIBA
9. Antiviral Agents (Antivirals)IBA
10. Peptides (Polypeptides)IBA

Therapies and Procedures

1. Therapeutics
2. Immunotherapy
3. Drug Therapy (Chemotherapy)
4. Transplantation
11/01/1996 - "Hospitals hosting a BMT Unit must fulfill several requirements which are crucial to guaranteeing the best results when faced with the complexity and aggressiveness of transplantation and possible complications, such as a blood bank, an infectious diseases department, a rehabilitation unit, the availability of consultants, as well as playworkers, teachers, psychologists and social workers. "
01/01/2013 - "In summary, our KIR MLPA assay allows rapid and accurate KIR genotyping and CNV detection, thus rendering improved transplantation programs and oncology treatment feasible, and enables more detailed studies on the role of KIRs in human (auto)immunity and infectious disease. "
01/27/2011 - "Improved technologies for the diagnosis of infectious diseases suggest possible changes to paradigms used in the screening of organ donors to prevent disease transmission with transplantation. "
12/27/2002 - "However, in the recent cohort of patients who underwent transplantation after September 1995, there were no fatal cases of Epstein-Barr virus or PTLD or late mortality thus far, suggesting a benefit from improved infectious disease surveillance using currently available modalities. "
02/01/1975 - "This patient's course illustrates the severity and chronicity of immunoincompetence associated with allogeneic marrow grafting, the importance of early detection and rigorous treatment of infectious disease in these patients, and the need for improved immunologic reconstitution in human marrow transplantation. "
5. Donor Selection